Matthew Edwards > Osborne Clarke LLP > London, England > Lawyer Profile

A range of multinational biopharmaceutical and medical device companies turn to Osborne Clarke LLP for assistance with work such as multi-jurisdictional patent litigation, life sciences M&A and financing transactions. A foursome of partners oversee the team: Will James‘ contentious IP expertise has seen him litigate before the UK courts and the UPC. Matthew Edwards is praised for his ‘smooth and successful’ handling of transactions. His corporate expertise is relied upon by the likes of BioNtech. Marcus Vass is well-versed in the digital health sector, and Richard Wilkinson heads up the firm’s healthcare subsector. Tim Harris is a further key contact and extends the unit’s international IP litigation strength.

Covering early-stage investment rounds, high-value fundraisings, and complex funding rounds, the ‘impressive, knowledgeable, and detail-oriented’ Osborne Clarke LLP works with a global client roster. Especially renowned for its work in the life sciences, renewable energy, and financial services sectors, the team routinely acts on behalf of both investors and investees in pre-seed investments, as well as spinouts and exits. Based in Thames Valley, practice head Robert Wood covers all aspects of the venture and growth capital market. Reading-based Justin Starling is noted for his tech sector expertise, while Thames Valley-based Rob Hayes advises clients on buy-and-build strategies and M&A activity. From London, Mathias Loertscher primarily focuses on the media and communications industries, while Matthew Edwards concentrates on strategic transactions and exits. Bristol-based James Taylor regularly advises investors and management teams. The Reading-based Elizabeth Yell is also recommended.